Statement Of Cash Flows [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183075

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
15 006 EUR
79 291 EUR
Adjustments for decrease (increase) in trade and other receivables
7 241 EUR
341,000 EUR
Adjustments for increase (decrease) in trade and other payables
18,232,000 EUR
4 449 EUR
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
11,940,000 EUR
10,426,000 EUR
Income taxes paid, classified as operating activities
322,000 EUR
- EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.